Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study
C. Bonifati(San Gallicano Hospital), Antonio Costanzo(Humanitas University), Leonardo Zichichi(Ospedale Sant Antonio), Claudia Lasagni(University of Modena and Reggio Emilia), Paolo Dapavo(University of Turin), Luca Stingeni(University of Perugia), Massimo Donini(University of Milan), S. Lembo(University of Salerno), Antonio Giovanni Richetta, Martina Burlando(Martin University), Talia Gramiccia(Janssen (Italy)), Concetta Potenza(Danieli (Italy)), Maria Rita Bongiorno(University of Palermo), Giuseppe Stinco(Unknown), A. Offidani(Marche Polytechnic University), Franco Rongioletti(Vita-Salute San Raffaele University), L. Atzori(University of Cagliari), Paola Savoia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Sabatino Pallotta(IRCCS Policlinico San Donato), Claudio Guarneri(University of Messina), Stefano Piaserico(University of Padua), Giuseppe Micali(University of Catania), Marco ROMANELLI(Scuola Superiore Sant'Anna), Vito Giuseppe Di Lernia(Azienda Usl 8 Arezzo), G. Argenziano(University of Campania "Luigi Vanvitelli"), Federico Bardazzi(Azienda USL di Bologna), Marco Galluzzo(University of Rome Tor Vergata), Francesca Satolli(University of Parma), Carlo Giovanni Carrera(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Maria Concetta Fargnoli(University of L'Aquila), Ketty Peris(Università Cattolica del Sacro Cuore), Federico Saibene(Johnson & Johnson (Israel)), Francesco Loconsole(University of Bari Aldo Moro), Claudia Giofrè(Université Ouaga II), Francesca Prignano(Institute of Dermatology), Manuela Papini(University of Perugia), Monica Corazza(University of Ferrara), Matteo Megna(University of Padua)
Cited by 1
Related Papers
Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling
|Journal of Clinical Investigation|2009|1k
Dermoscopy in General Dermatology: A Practical Overview
|Dermatology and Therapy|2016|389
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement
|Clinical & Experimental Immunology|2004|230